Legal framework

Farmaindustria respects the ruling on tenders in Andalusia, but highlights the negative consequences they may generate

It proposes a national and long term vision as far as pharmaceutical policy is concerned.

EFPIA report on BREXIT consequences: Assessing the impact on the life sciences industry of a change in the UK relationship with the EU

Download document

Farmaindustria and the Ministries of Finance and Health sign a Protocol for sustainability, access and innovation

The agreement will have duration of 12-months, with the possibility of it being extended, and will take effect from December 1st

The pharmaceutical industry is the industrial sector which has increased its production the most since the crisis began

Publication of issue #112 of the Spanish pharmaceutical market in Spain’s Monthly Bulletin 

Farmaindustria requests a specific regulatory framework for biological medicines

A third of all international approved medicines already have a biological origin

FARMAINDUSTRIA lodges a new appeal against the Andalusian framework agreement for therapeutic equivalents

It has been presented before the First Instance Administrative Court in Seville 

FARMAINDUSTRIA will lodge an appeal against the Andalusian framework agreement for therapeutic equivalents

It represents a new attack on territorial equity and pharmaceutical provisions that Andalusian patients receive from the NHS 

Monthly Bulletin 107

FormatPDF  - Size885 kb
Download document

Farmaindustria will pursue legal actions against the Regional Government of Andalusia for their fourth call for tenders for a se-lection of medicines

Farmaindustria considers that it breaches current legislations, and trusts that the Central Government will appeal this measure before the Spanish Constitutional Court

© 2022 FarmaIndustria All rights reserved